author-photo

Christine Mauz-Körholz

Martin Luther University of Halle-Wittenberg
University of Giessen

101

Papers

1558

Citations

Citation Trend

Filter By

Papers (66) Sort By

Journal Conference Others

Late Effects After Treatment of Hodgkin Lymphoma in Childhood and Adolescence

2021
Show All
- Source
- Cite
- Save
Citations (0)
Molekulare Tumortherapie: Phase-I/II-Netzwerkstruktur der Gesellschaft für Pädiatrische Onkologie und Hämatologie

2021 Onkologe
Show All
- Source
- Cite
- Save
Citations (2)
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial.

2021 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group

2020
Show All
- Source
- Cite
- Save
Citations (6)
Phase 2, open-label study of pembrolizumab in children and young adults with newly diagnosed classical hodgkin lymphoma (cHL) with slow early response (SER) to frontline chemotherapy: KEYNOTE-667

2020
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of interim PET response to relapse vs. first-line treatment in children with classical Hodgkin lymphoma (HL) – contribution to the development of response criteria for relapsed HL

2020
Show All
- Source
- Cite
- Save
Citations (0)
HL-032: Nivolumab and Brentuximab Vedotin (BV)–Based, Response-Adapted Treatment in Children, Adolescents, and Young Adults (CAYA) With Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL): Primary Analysis of the Standard-Risk Cohort of the Phase 2 CheckMate 744 Study

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Nivolumab and brentuximab vedotin (BV)-based, response‐adapted treatment in children, adolescents, and young adults (CAYA) with standard-risk relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Primary analysis.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
The impact of the Point-spread-function (PSF) reconstruction on the response assessment in the Interim-PET (iPET) in Hodgkin lymphoma (HL)

2020
Show All
- Source
- Cite
- Save
Citations (0)
CT-morphologic vs. metabolic tumor volume in pediatric Hodgkin-Lymphoma - A comparison of 19 different semiautomatic delineation methods

2020
Show All
- Source
- Cite
- Save
Citations (0)